Meinian Onehealth Healthcare Holdings Co., Ltd. (002044.SZ)
CNY 4.92
(-1.2%)
CNY 4.92
(-1.2%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.53 Billion CNY | 117.04% |
| 2022 | 856.49 Million CNY | -37.21% |
| 2021 | 2.06 Billion CNY | -9.09% |
| 2020 | 1.88 Billion CNY | 41.27% |
| 2019 | 676.69 Million CNY | -21.33% |
| 2018 | 2.12 Billion CNY | 51.57% |
| 2017 | 1.16 Billion CNY | 88.72% |
| 2016 | 825.09 Million CNY | 43.92% |
| 2015 | 453.49 Million CNY | 299.15% |
| 2014 | 244.63 Million CNY | 23.97% |
| 2013 | 400.75 Thousand CNY | -4.71% |
| 2012 | 93.05 Million CNY | -0.09% |
| 2011 | 93.06 Million CNY | 112.51% |
| 2010 | 44.82 Million CNY | -3.37% |
| 2009 | 42.23 Million CNY | 40.46% |
| 2008 | 33.88 Million CNY | -33.97% |
| 2007 | 48.45 Million CNY | 9.0% |
| 2006 | 46.64 Million CNY | 14.47% |
| 2005 | 40.71 Million CNY | 1.56% |
| 2004 | 40.09 Million CNY | 42.24% |
| 2003 | 28.18 Million CNY | 22.68% |
| 2002 | 22.97 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 410.71 Million CNY | -20.29% |
| 2024 Q2 | 522.24 Million CNY | 320.86% |
| 2024 Q1 | -233.3 Million CNY | -125.27% |
| 2023 Q1 | -74 Million CNY | -156.89% |
| 2023 Q4 | 929.77 Million CNY | 121.61% |
| 2023 FY | - CNY | 117.04% |
| 2023 Q3 | 419.54 Million CNY | 64.63% |
| 2023 Q2 | 254.83 Million CNY | 444.36% |
| 2022 FY | - CNY | -37.21% |
| 2022 Q1 | -433.41 Million CNY | -156.37% |
| 2022 Q2 | -174.83 Million CNY | 59.66% |
| 2022 Q3 | 523.92 Million CNY | 399.66% |
| 2022 Q4 | 130.08 Million CNY | -75.17% |
| 2021 Q1 | -392.78 Million CNY | -120.51% |
| 2021 FY | - CNY | -9.09% |
| 2021 Q2 | 85.35 Million CNY | 121.73% |
| 2021 Q3 | 369.81 Million CNY | 333.24% |
| 2021 Q4 | 768.88 Million CNY | 107.91% |
| 2020 Q2 | -140.93 Million CNY | 78.36% |
| 2020 Q4 | 1.91 Billion CNY | 243.36% |
| 2020 Q3 | 557.61 Million CNY | 495.64% |
| 2020 FY | - CNY | 41.27% |
| 2020 Q1 | -651.32 Million CNY | -279.9% |
| 2019 Q2 | 548.81 Million CNY | 306.16% |
| 2019 FY | - CNY | -21.33% |
| 2019 Q1 | -266.2 Million CNY | -137.39% |
| 2019 Q3 | 615.33 Million CNY | 12.12% |
| 2019 Q4 | 362.05 Million CNY | -41.16% |
| 2018 Q2 | 520.28 Million CNY | 670.35% |
| 2018 FY | - CNY | 51.57% |
| 2018 Q1 | -91.22 Million CNY | -113.94% |
| 2018 Q4 | 711.98 Million CNY | 62.82% |
| 2018 Q3 | 437.27 Million CNY | -15.95% |
| 2017 FY | - CNY | 88.72% |
| 2017 Q1 | -103.13 Million CNY | -127.33% |
| 2017 Q4 | 654.52 Million CNY | 152.0% |
| 2017 Q3 | 259.73 Million CNY | 20.14% |
| 2017 Q2 | 216.18 Million CNY | 309.61% |
| 2016 FY | - CNY | 43.92% |
| 2016 Q1 | -160.97 Million CNY | -152.17% |
| 2016 Q2 | 157.16 Million CNY | 197.64% |
| 2016 Q4 | 377.38 Million CNY | 111.99% |
| 2016 Q3 | 178.02 Million CNY | 13.27% |
| 2015 Q3 | 98.78 Million CNY | 546.05% |
| 2015 Q1 | 4.54 Million CNY | -67.26% |
| 2015 FY | - CNY | 299.15% |
| 2015 Q2 | 15.29 Million CNY | 236.41% |
| 2015 Q4 | 308.52 Million CNY | 212.31% |
| 2014 Q3 | 65.55 Million CNY | 229.75% |
| 2014 FY | - CNY | 23.97% |
| 2014 Q4 | 13.88 Million CNY | -78.82% |
| 2014 Q2 | 19.87 Million CNY | 549.69% |
| 2014 Q1 | 3.05 Million CNY | -84.07% |
| 2013 Q3 | 43.15 Million CNY | 617.67% |
| 2013 Q4 | 19.2 Million CNY | -55.5% |
| 2013 FY | - CNY | -4.71% |
| 2013 Q1 | 5.16 Million CNY | -84.28% |
| 2013 Q2 | 6.01 Million CNY | 16.48% |
| 2012 Q2 | 7.44 Million CNY | -13.35% |
| 2012 FY | - CNY | -0.09% |
| 2012 Q4 | 32.84 Million CNY | -6.48% |
| 2012 Q3 | 35.11 Million CNY | 371.88% |
| 2012 Q1 | 8.58 Million CNY | -72.29% |
| 2011 Q2 | 7.12 Million CNY | -15.38% |
| 2011 FY | - CNY | 112.51% |
| 2011 Q4 | 30.99 Million CNY | -11.21% |
| 2011 Q3 | 34.9 Million CNY | 389.87% |
| 2011 Q1 | 8.42 Million CNY | -21.12% |
| 2010 FY | - CNY | -3.37% |
| 2010 Q2 | 7.15 Million CNY | 313.66% |
| 2010 Q3 | 16.45 Million CNY | 130.2% |
| 2010 Q1 | 1.72 Million CNY | -91.99% |
| 2010 Q4 | 10.67 Million CNY | -35.14% |
| 2009 Q4 | 21.59 Million CNY | 97.85% |
| 2009 Q2 | 5.11 Million CNY | 233.7% |
| 2009 Q3 | 10.91 Million CNY | 113.26% |
| 2009 FY | - CNY | 40.46% |
| 2009 Q1 | 1.53 Million CNY | -72.82% |
| 2008 Q4 | 5.64 Million CNY | -57.48% |
| 2008 Q2 | 5.64 Million CNY | 1197.93% |
| 2008 FY | - CNY | -33.97% |
| 2008 Q3 | 13.27 Million CNY | 135.19% |
| 2008 Q1 | -513.92 Thousand CNY | -104.45% |
| 2007 FY | - CNY | 9.0% |
| 2007 Q2 | 4.96 Million CNY | -1.94% |
| 2007 Q3 | 18.34 Million CNY | 269.12% |
| 2007 Q4 | 11.54 Million CNY | -37.07% |
| 2007 Q1 | 5.06 Million CNY | -53.39% |
| 2006 Q3 | 21.23 Million CNY | 183.68% |
| 2006 FY | - CNY | 14.47% |
| 2006 Q4 | 10.87 Million CNY | -48.8% |
| 2006 Q1 | 7.13 Million CNY | -37.5% |
| 2006 Q2 | 7.48 Million CNY | 4.88% |
| 2005 Q4 | 11.41 Million CNY | -38.64% |
| 2005 Q2 | 1.88 Million CNY | -39.75% |
| 2005 Q1 | 3.13 Million CNY | -68.34% |
| 2005 Q3 | 18.61 Million CNY | 886.75% |
| 2005 FY | - CNY | 1.56% |
| 2004 Q3 | 13.93 Million CNY | 0.0% |
| 2004 Q4 | 9.88 Million CNY | -29.07% |
| 2004 FY | - CNY | 42.24% |
| 2003 FY | - CNY | 22.68% |
| 2002 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 2.55 Billion CNY | 0.703% |
| Aier Eye Hospital Group Co., Ltd. | 6.09 Billion CNY | 58.34% |